Cargando…

Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives

Gene therapy has promised to be a highly effective antitumor treatment by introducing a tumor suppressor gene or the abrogation of an oncogene. Among the potential therapeutic transgenes, the tumor suppressor gene p53 serves as an attractive target. Restoration of wild-type p53 function in tumors ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Guang-xia, Zhang, Shu, He, Xiao-hua, Liu, Shi-yu, Ma, Chao, Zou, Xiao-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211860/ https://www.ncbi.nlm.nih.gov/pubmed/25364261 http://dx.doi.org/10.2147/OTT.S50483

Ejemplares similares

Efficacy of Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural or Peritoneal Effusions
por: ZHANG, Xin, et al.
Publicado: (2013)

Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives
por: Vetrini, Francesco, et al.
Publicado: (2010)

Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors
por: SUN, Q.F., et al.
Publicado: (2015)

Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro
por: Gribova, I.Yu., et al.
Publicado: (2011)

Seamless assembly of recombinant adenoviral genomes from high-copy plasmids
por: Miciak, Jessica J., et al.
Publicado: (2018)

Cationic Liposome Conjugation to Recombinant Adenoviral Vector Reduces Viral Antigenicity
por: Natsume, Atsushi, et al.
Publicado: (2000)

Adenoviral Vector Driven by a Minimal Rad51 Promoter Is Selective for p53-Deficient Tumor Cells
por: Fong, Vincent, et al.
Publicado: (2011)

Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma
por: Sobol, Robert E., et al.
Publicado: (2021)

Stability of a Recombinant Adenoviral Vector: Optimization of Conditions for Storage, Transport and Delivery
por: Ugai, Hideyo, et al.
Publicado: (2002)

Bacterial RecA Protein Promotes Adenoviral Recombination during In Vitro Infection
por: Lee, Jeong Yoon, et al.
Publicado: (2018)

A Novel and Simple Method for Rapid Generation of Recombinant Porcine Adenoviral Vectors for Transgene Expression
por: Zhang, Peng, et al.
Publicado: (2015)

Updates and New Perspectives on Adenoviral Gene Therapy and Vaccine Vectors
por: Dobner, Thomas, et al.
Publicado: (2023)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

(1)IFN-α Modulates Memory Tfh Cells and Memory B Cells in Mice, Following Recombinant FMDV Adenoviral Challenge
por: Duan, Xiangguo, et al.
Publicado: (2020)

Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
por: Chavda, Vivek P., et al.
Publicado: (2023)

Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study
por: Deng, Bo, et al.
Publicado: (2017)

Adenoviral Producer Cells
por: Kovesdi, Imre, et al.
Publicado: (2010)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

Recombinant adenoviral microRNA-206 induces myogenesis in C2C12 cells
por: Zhang, Weiwei, et al.
Publicado: (2011)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
por: Zhang, Jianfeng
Publicado: (2012)

Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies
por: Pacesa, Martin, et al.
Publicado: (2017)

Adenoviral vector mediated ferritin over-expression in mesenchymal stem cells detected by 7T MRI in vitro
por: Dai, Hai-yang, et al.
Publicado: (2017)

A p53-independent apoptotic mechanism of adenoviral mutant E1A was involved in its selective antitumor activity for human cancer
por: Fang, Lin, et al.
Publicado: (2016)

Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
por: Hunger, Aline, et al.
Publicado: (2017)

Discrimination of Kawasaki disease with concomitant adenoviral detection differentiating from isolated adenoviral infection
por: Kim, Jong Han, et al.
Publicado: (2018)

Encoding and Decoding of p53 Dynamics in Cellular Response to Stresses
por: Wang, Ping, et al.
Publicado: (2023)

The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment
por: Li, Dan-Dan, et al.
Publicado: (2012)

Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective
por: JT, Schwartze, et al.
Publicado: (2022)

Effect of CGRP-Adenoviral Vector Transduction on the Osteoblastic Differentiation of Rat Adipose-Derived Stem Cells
por: Fang, Zhong, et al.
Publicado: (2013)

Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector
por: Vermeij, J, et al.
Publicado: (2001)

Pathogenesis and management of adenoviral keratoconjunctivitis
por: Chigbu, DeGaulle I, et al.
Publicado: (2018)

ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION
por: Von Seggern, Dan J., et al.
Publicado: (1999)

Construction and application of adenoviral vectors
por: Zhang, Hongbo, et al.
Publicado: (2023)

Dynamic distribution and expression in vivo of the human interferon gamma gene delivered by adenoviral vector
por: Wu, Jiangxue, et al.
Publicado: (2009)

Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases
por: Alhashimi, Marwa, et al.
Publicado: (2021)

Production of p53 gene knockout rats by homologous recombination in embryonic stem cells
por: Tong, Chang, et al.
Publicado: (2010)

Adenoviral vector-based strategies against infectious disease and cancer
por: Zhang, Chao, et al.
Publicado: (2016)

Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection
por: Callahan, Shellie M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_63ldfc72ejjbfi6u0ktip1ucun